Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384X), (10.1016/j.biopha.2021.111599))

Elmira Mohammadi, Fatemeh Shafiee, Kiana Shahzamani, Mohammad Mehdi Ranjbar, Abbas Alibakhshi, Shahrzad Ahangarzadeh*, Leila Beikmohammadi, Laleh Shariati, Soodeh Hooshmandi, Behrooz Ataei, Shaghayegh HaghjooyJavanmard

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorPopular

Abstract

The authors regret the incorrect publication of affiliations of some of the authors in the original article. The correct affiliation of the authors are presented below: Elmira Mohammadia,b Fatemeh Shafieec Kiana Shahzamanid Mohammad Mehdi Ranjbare Abbas Alibakhshif Shahrzad Ahangarzadehg Leila Beikmohammadih,i Laleh Shariatij,k Soodeh Hooshmandil Behrooz Ataeim Shaghayegh HaghjooyJavanmarda a Applied Physiology Research Center, Cardiovascular Research Institute, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran b Core Research Facilities, Isfahan University of Medical Sciences, Isfahan, Iran c Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran d Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of medical sciences, Isfahan, Iran e Razi Vaccine and Serum Research Institute, Agricultural Research, Education, and Extension Organization (AREEO), Karaj, Iran f Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran g Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran h Department of Biochemistry, Erasmus University Medical Center, Rotterdam, The Netherlands i Stem Cell and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, 14155-6559 Tehran, Iran j Biosensor Research Center, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran k Department of Biomaterials, Nanotechnology and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran l Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran m Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number111723
JournalBiomedicine and Pharmacotherapy
Volume140
DOIs
Publication statusPublished - Aug 2021

Fingerprint

Dive into the research topics of 'Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384X), (10.1016/j.biopha.2021.111599))'. Together they form a unique fingerprint.

Cite this